Reprospher 100 CN

Cyano-Bonded HPLC Column for Balanced Polar and Hydrophobic Selectivity

Reprospher 100 CN is a high-performance HPLC column from Dr. Maisch HPLC GmbH, packed with ultra-pure, fully porous spherical silica bonded with cyano functional groups. This stationary phase provides a balanced retention profile, combining moderate hydrophobic interactions with polar selectivity, making it suitable for both reversed-phase and normal-phase chromatography. Its dual-mode capability makes Reprospher 100 CN an excellent choice for method development and applications where alternative selectivity to C18 or C8 phases is required.

Reprospher 100 CN from Dr. Maisch HPLC GmbH offers versatile dual-mode performance – ideal for laboratories seeking balanced retention and flexible selectivity in modern HPLC.

Key Features:

  • Cyano-bonded silica – USP L10 classification

  • Moderate hydrophobic retention with polar interaction capability

  • Suitable for both reversed-phase and normal-phase separations

  • Fully porous, high-purity 100 Å spherical silica

  • Manufactured and quality-controlled by Dr. Maisch HPLC GmbH

  • Available in from 1.8 µm to 10 µm particle sizes

Typical Applications:

  • Fast separations of moderately polar analytes

  • Reversed-phase LC of compounds with limited C18 retention

  • Normal-phase chromatography of polar organics

  • Method scouting for orthogonal selectivity

Specifications

Request Product
Particle Sizes
  • 1.8 µm
  • 2 µm
  • 2.5 µm
  • 3 µm
  • 5 µm
  • 10 µm
Pore Size 100 Å
Surface Area 350 m²/g
Phase/Modification CN
Particle Type
Separation Modes
USP Code
Endcapping No
Carbonload 7 %
pH Range 2 to 8

Material Numbers

Phase Material Number
Reprospher 100 CN, 1.8 µm rs.118.c0.
Reprospher 100 CN, 2 µm rs12.c0.
Reprospher 100 CN, 2.5 µm rs125.c0.
Reprospher 100 CN, 3 µm rs.13.c0.
Reprospher 100 CN, 5 µm rs15.c0.
Reprospher 100 CN, 10 µm rs10.c0.
Reprospher 100 C30-DE Reprospher 100 CN-DE

Any questions?
We are here to help you.

info@dr-maisch.com +49 7073 5035 7

Follow us